PB
JAZZ icon

Pinnacle Bancorp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pinnacle Bancorp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.59K Sell
19
-7
-27% -$1.22K ﹤0.01% 833
2025
Q4 		$4.42K Hold
26
– – ﹤0.01% 798
2025
Q3 		$3.43K Sell
26
-21
-45% -$2.52K ﹤0.01% 838
2025
Q2 		$4.99K Hold
47
– – ﹤0.01% 798
2025
Q1 		$5.83K Hold
47
– – ﹤0.01% 758
2024
Q4 		$5.79K Hold
47
– – ﹤0.01% 771
2024
Q3 		$5.24K Hold
47
– – ﹤0.01% 775
2024
Q2 		$5.02K Buy
47
+11
+31% +$1.21K ﹤0.01% 755
2024
Q1 		$4.33K Buy
36
+19
+112% +$2.33K ﹤0.01% 748
2023
Q4 		$2.09K Buy
17
+8
+89% +$998 ﹤0.01% 773
2023
Q3 		$1.17K Buy
+9
New +$1.2K ﹤0.01% 769

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Pinnacle Bancorp's JAZZ Position: Q1 2026 in Review

Pinnacle Bancorp reduced its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q1 2026, selling an estimated $1.22K and leaving 19 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

Pinnacle Bancorp first reported a position in JAZZ in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.83K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Pinnacle Bancorp held 19 shares of Jazz Pharmaceuticals worth $3.59K as of Q1 2026.
  • Pinnacle Bancorp sold 7 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.22K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q1 2026, its #833 holding.
  • Pinnacle Bancorp first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • Pinnacle Bancorp's Jazz Pharmaceuticals position peaked at $5.83K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.